F-10981

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameF-10981
Drug Alias NameF-10981
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 antagonists
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut De Recherche Pierre Fabre Sas
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut De Recherche Pierre Fabre Sas
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A